Intel posts an $11 billion loss in recent earnings despite revenue beat, signaling deep restructuring.
Intel's second-quarter earnings report presented a paradox: strong operational results overshadowed by a substantial restructuring charge that sent the stock tumbling after an initial rally.
Though Intel's Q2 revenue surpassed expectations at $16.1 billion—25% higher year-over-year and well above Wall Street's estimate of $14.4 billion—shares retreated sharply as investors reacted to the company's $11 billion net loss. Trading nearly 10% higher in after-hours initially, the stock surrendered gains as the market weighed the scale of restructuring costs against operational improvements. Gross margins expanded dramatically to 40.4% on a GAAP basis, with adjusted earnings at $0.42 per share, reversing a $0.10 loss in the prior-year quarter. Yet the $11 billion net loss, or $2.16 per share (compared with a $2.9 billion loss a year earlier), dominated investor sentiment and capped further upside.
Intel projects Q3 revenue of $15.8 billion to $16.8 billion, with reported EPS of $0.31 and adjusted EPS of $0.38. Management's guidance suggests sustained demand for server processors in the coming months, though investors remain focused on whether this represents a durable recovery or a single strong quarter.
At the heart of Wall Street's cautious optimism lies Intel's 18A process technology. The company has raised manufacturing yields to approximately 85% from around 65% three months prior. High-volume production of Core Ultra Series 3 processors has begun using ASML's High-NA EUV technology, while the improved 18A-P process entered risk production. Intel unveiled its first 18A-node server processor, Xeon 6+, and announced partnerships with SambaNova and Foxconn for AI infrastructure. Notably, over 130 customers are testing Intel's new Core Ultra and Core Series 3 chips for edge AI and robotics applications, signaling early commercial traction.
Analyst sentiment became more constructive ahead of earnings. KeyBanc raised its target to $155, UBS to $121, and both TD Cowen and Susquehanna to $115. Citi maintained its Buy rating with a $130 target, projecting Intel could capture nearly half the CPU market by 2030. HSBC remains the most bullish at $200, while Rosenblatt stands alone with a Sell rating and $65 target, citing persistent manufacturing risks. The consensus holds at approximately $113.72 across 30 analysts—8 buys, 20 holds, and 2 sells—suggesting some downside from current levels.
Competitive pressures persist. AMD continues to threaten Intel's dominance in data centers, and some analysts warn that memory shortages could further pressure PC sales and margins through the second half of 2026.
From a technical standpoint, Intel trades near $103.30 within a descending channel favoring bears. Resistance sits near the 50-period EMA at $105.68 and the 200-period EMA at $108.03, characterized by lower highs and lower lows. RSI has moved to 50.9, indicating reduced selling pressure but no yet oversold conditions. A decisive break above $105.68 would clear the way toward $106.72 and $108.03. Support levels lie at $96.74; failure to hold above that level would open downside toward $89.45. The stock remains at a technical turning point requiring a break and close above the descending channel to confirm sustained recovery momentum.
Intel's path forward hinges on execution. The company must sustain 18A manufacturing progress, drive foundry adoption, capitalize on enterprise AI demand, and return to profitable growth. The $11 billion loss underscores that turnaround costs remain steep. Coming quarters will reveal whether operational improvements can ultimately justify the restructuring price tag or whether the heavy transition burden will continue to overshadow better business fundamentals.